189 related articles for article (PubMed ID: 21604240)
41. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4).
Modarai M; Yang M; Suter A; Kortenkamp A; Heinrich M
Planta Med; 2010 Mar; 76(4):378-85. PubMed ID: 19790031
[TBL] [Abstract][Full Text] [Related]
42. Echinacea: anatomy, phytochemical pattern, and germination of the achene.
Schulthess BH; Giger E; Baumann TW
Planta Med; 1991 Aug; 57(4):384-8. PubMed ID: 1775583
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the pharmacokinetics of hawthorn phenolics in extract versus individual pure compound.
Chang Q; Zuo Z; Ho WK; Chow MS
J Clin Pharmacol; 2005 Jan; 45(1):106-12. PubMed ID: 15601812
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetic properties of pure xanthones in comparison to a mangosteen fruit extract in rats.
Li L; Han AR; Kinghorn AD; Frye RF; Derendorf H; Butterweck V
Planta Med; 2013 May; 79(8):646-53. PubMed ID: 23673465
[TBL] [Abstract][Full Text] [Related]
45. Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides.
Raduner S; Bisson W; Abagyan R; Altmann KH; Gertsch J
J Nat Prod; 2007 Jun; 70(6):1010-5. PubMed ID: 17497806
[TBL] [Abstract][Full Text] [Related]
46. Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy.
Micheli L; Maggini V; Ciampi C; Gallo E; Bogani P; Fani R; Pistelli L; Ghelardini C; Di Cesare Mannelli L; De Leo M; Firenzuoli F
Phytother Res; 2023 May; 37(5):1911-1923. PubMed ID: 36578266
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of brucine after intravenous and oral administration to rats.
Chen J; Xiao HL; Hu RR; Hu W; Chen ZP; Cai H; Liu X; Lu TL; Fang Y; Cai BC
Fitoterapia; 2011 Dec; 82(8):1302-8. PubMed ID: 21958965
[TBL] [Abstract][Full Text] [Related]
48. Life-threatening interaction between the root extract of Pueraria lobata and methotrexate in rats.
Chiang HM; Fang SH; Wen KC; Hsiu SL; Tsai SY; Hou YC; Chi YC; Chao PD
Toxicol Appl Pharmacol; 2005 Dec; 209(3):263-8. PubMed ID: 15936791
[TBL] [Abstract][Full Text] [Related]
49. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
50. Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion.
Matthias A; Addison RS; Penman KG; Dickinson RG; Bone KM; Lehmann RP
Life Sci; 2005 Sep; 77(16):2018-29. PubMed ID: 15919096
[TBL] [Abstract][Full Text] [Related]
51. Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza, in rat.
Zhang Y; Akao T; Nakamura N; Duan CL; Hattori M; Yang XW; Liu JX
Planta Med; 2004 Feb; 70(2):138-42. PubMed ID: 14994191
[TBL] [Abstract][Full Text] [Related]
52. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
[TBL] [Abstract][Full Text] [Related]
53. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats.
Jeong DW; Kim YH; Kim HH; Ji HY; Yoo SD; Choi WR; Lee SM; Han CK; Lee HS
Biopharm Drug Dispos; 2007 Mar; 28(2):51-7. PubMed ID: 17163409
[TBL] [Abstract][Full Text] [Related]
54. A pharmacokinetic study on Z-(+/-)-2-(1-benzylindole-3-yl-methylene)azabicyclo[2.2.2]octane-3-ol; a novel radio-sensitization agent.
Al-Ghananeem AM; Albayati ZF; Malkawi A; Sonar VN; Freeman ML; Crooks PA
Cancer Chemother Pharmacol; 2007 Nov; 60(6):915-9. PubMed ID: 17294191
[TBL] [Abstract][Full Text] [Related]
55. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.
Gorski JC; Huang SM; Pinto A; Hamman MA; Hilligoss JK; Zaheer NA; Desai M; Miller M; Hall SD
Clin Pharmacol Ther; 2004 Jan; 75(1):89-100. PubMed ID: 14749695
[TBL] [Abstract][Full Text] [Related]
56. Agrobacterium rhizogenes-mediated transformation of Echinacea purpurea.
Trypsteen M; Van Lijsebettens M; Van Severen R; Van Montagu M
Plant Cell Rep; 1991 Jun; 10(2):85-9. PubMed ID: 24221400
[TBL] [Abstract][Full Text] [Related]
57. Biochemometric Analysis of Fatty Acid Amide Hydrolase Inhibition by Echinacea Root Extracts.
Liu R; Burkett K; Rapinski M; Arnason JT; Johnson F; Hintz P; Baker J; Harris CS
Planta Med; 2021 Apr; 87(4):294-304. PubMed ID: 33296937
[TBL] [Abstract][Full Text] [Related]
58.
Hasa D; Žakelj S; Grabnar I; Cilurzo F; Dall'Acqua S; Riva A; Perissutti B; Voinovich D
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33207557
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics and bioavailability of cimicifugosides after oral administration of Cimicifuga foetida L. extract to rats.
Gai YY; Liu WH; Sha CJ; Wang YL; Sun YT; Li XJ; Paul Fawcett J; Gu JK
J Ethnopharmacol; 2012 Aug; 143(1):249-55. PubMed ID: 22771280
[TBL] [Abstract][Full Text] [Related]
60. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
